About BioPheresis
Biopheresis has developed a new patent protected blood treatment system designed to remove certain immune-inhibitors from the blood that protect certain cancers from the immune system. Biopheresis’ system has not received CE mark or FDA approval and therefore is not available for clinical use.
Facts about BioPheresis
Facts about BioPheresis
- Focus : Laboratory
- Industry : Biotechnology
